Loading…
Lobbying Spend
—
Filings
18
Firms Hired
1
Active Period
2019–2023
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Elijah E. Cummings Lower Drug Costs Now Act
2022 · second_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3
Inflation Reduction Act of 2022
2022 · second_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $10,000
Matched citations: H.R. 5376
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $10,000
Matched citations: H.R. 6000
Increasing Access to Biosimilars Act of 2021
2022 · second_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $10,000
Matched citations: S. 1427
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $10,000
Matched citations: S. 1898
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $10,000
Matched citations: S. 3799
Medicare Drug Price Negotiation Act
2022 · second_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $10,000
Matched citations: S. 908
Prescription Drug Price Relief Act of 2021
2022 · second_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $10,000
Matched citations: S. 909
Elijah E. Cummings Lower Drug Costs Now Act
2022 · first_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3
Inflation Reduction Act of 2022
2022 · first_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5376
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6000
Increasing Access to Biosimilars Act of 2021
2022 · first_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $30,000
Matched citations: S. 1427
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $30,000
Matched citations: S. 1898
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $30,000
Matched citations: S. 3799
Medicare Drug Price Negotiation Act
2022 · first_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $30,000
Matched citations: S. 908
Prescription Drug Price Relief Act of 2021
2022 · first_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions S. 1898 (Affordable Medications Act), all provisions H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 6000 (Cures 2.0 Act), all provisions S. 3799 (PREVENT Pandemics Act), Title V, regarding drug manufacturing
Client expense: — · Firm income: $30,000
Matched citations: S. 909
Elijah E. Cummings Lower Drug Costs Now Act
2021 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 5801 (HELP Copays Act), all provisions
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3
Inflation Reduction Act of 2022
2021 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 5801 (HELP Copays Act), all provisions
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5376
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 5801 (HELP Copays Act), all provisions
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5801
Increasing Access to Biosimilars Act of 2021
2021 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 5801 (HELP Copays Act), all provisions
Client expense: — · Firm income: $30,000
Matched citations: S. 1427
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 5801 (HELP Copays Act), all provisions
Client expense: — · Firm income: $30,000
Matched citations: S. 1898
Medicare Drug Price Negotiation Act
2021 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 5801 (HELP Copays Act), all provisions
Client expense: — · Firm income: $30,000
Matched citations: S. 908
Prescription Drug Price Relief Act of 2021
2021 · fourth_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 5801 (HELP Copays Act), all provisions
Client expense: — · Firm income: $30,000
Matched citations: S. 909
Elijah E. Cummings Lower Drug Costs Now Act
2021 · third_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3
Inflation Reduction Act of 2022
2021 · third_quarter · Firm: ARENTFOX SCHIFF LLP
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5376
Source: Senate LDA